Cargando…

Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles

BACKGROUND: Numerous studies have revealed the relationship between lipid expression and increased cardiovascular risk in ST-segment elevation myocardial infarction (STEMI) patients. Nevertheless, few investigations have focused on the risk stratification of STEMI patients using machine learning alg...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yuzhou, Shen, Jian, Hong, Weifeng, Zhou, Wei, Xiang, Zhenxian, Zhu, Yuansong, Huang, Chuiguo, Luo, Suxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101132/
https://www.ncbi.nlm.nih.gov/pubmed/33957898
http://dx.doi.org/10.1186/s12944-021-01475-z
_version_ 1783688910082146304
author Xue, Yuzhou
Shen, Jian
Hong, Weifeng
Zhou, Wei
Xiang, Zhenxian
Zhu, Yuansong
Huang, Chuiguo
Luo, Suxin
author_facet Xue, Yuzhou
Shen, Jian
Hong, Weifeng
Zhou, Wei
Xiang, Zhenxian
Zhu, Yuansong
Huang, Chuiguo
Luo, Suxin
author_sort Xue, Yuzhou
collection PubMed
description BACKGROUND: Numerous studies have revealed the relationship between lipid expression and increased cardiovascular risk in ST-segment elevation myocardial infarction (STEMI) patients. Nevertheless, few investigations have focused on the risk stratification of STEMI patients using machine learning algorithms. METHODS: A total of 1355 STEMI patients who underwent percutaneous coronary intervention were enrolled in this study during 2015–2018. Unsupervised machine learning (consensus clustering) was applied to the present cohort to classify patients into different lipid expression phenogroups, without the guidance of clinical outcomes. Kaplan-Meier curves were implemented to show prognosis during a 904-day median follow-up (interquartile range: 587–1316). In the adjusted Cox model, the association of cluster membership with all adverse events including all-cause mortality, all-cause rehospitalization, and cardiac rehospitalization was evaluated. RESULTS: All patients were classified into three phenogroups, 1, 2, and 3. Patients in phenogroup 1 with the highest Lp(a) and the lowest HDL-C and apoA1 were recognized as the statin-modified cardiovascular risk group. Patients in phenogroup 2 had the highest HDL-C and apoA1 and the lowest TG, TC, LDL-C and apoB. Conversely, patients in phenogroup 3 had the highest TG, TC, LDL-C and apoB and the lowest Lp(a). Additionally, phenogroup 1 had the worst prognosis. Furthermore, a multivariate Cox analysis revealed that patients in phenogroup 1 were at significantly higher risk for all adverse outcomes. CONCLUSION: Machine learning-based cluster analysis indicated that STEMI patients with increased concentrations of Lp(a) and decreased concentrations of HDL-C and apoA1 are likely to have adverse clinical outcomes due to statin-modified cardiovascular risks. TRIAL REGISTRATION: ChiCTR1900028516 (http://www.chictr.org.cn/index.aspx). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01475-z.
format Online
Article
Text
id pubmed-8101132
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81011322021-05-06 Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles Xue, Yuzhou Shen, Jian Hong, Weifeng Zhou, Wei Xiang, Zhenxian Zhu, Yuansong Huang, Chuiguo Luo, Suxin Lipids Health Dis Research BACKGROUND: Numerous studies have revealed the relationship between lipid expression and increased cardiovascular risk in ST-segment elevation myocardial infarction (STEMI) patients. Nevertheless, few investigations have focused on the risk stratification of STEMI patients using machine learning algorithms. METHODS: A total of 1355 STEMI patients who underwent percutaneous coronary intervention were enrolled in this study during 2015–2018. Unsupervised machine learning (consensus clustering) was applied to the present cohort to classify patients into different lipid expression phenogroups, without the guidance of clinical outcomes. Kaplan-Meier curves were implemented to show prognosis during a 904-day median follow-up (interquartile range: 587–1316). In the adjusted Cox model, the association of cluster membership with all adverse events including all-cause mortality, all-cause rehospitalization, and cardiac rehospitalization was evaluated. RESULTS: All patients were classified into three phenogroups, 1, 2, and 3. Patients in phenogroup 1 with the highest Lp(a) and the lowest HDL-C and apoA1 were recognized as the statin-modified cardiovascular risk group. Patients in phenogroup 2 had the highest HDL-C and apoA1 and the lowest TG, TC, LDL-C and apoB. Conversely, patients in phenogroup 3 had the highest TG, TC, LDL-C and apoB and the lowest Lp(a). Additionally, phenogroup 1 had the worst prognosis. Furthermore, a multivariate Cox analysis revealed that patients in phenogroup 1 were at significantly higher risk for all adverse outcomes. CONCLUSION: Machine learning-based cluster analysis indicated that STEMI patients with increased concentrations of Lp(a) and decreased concentrations of HDL-C and apoA1 are likely to have adverse clinical outcomes due to statin-modified cardiovascular risks. TRIAL REGISTRATION: ChiCTR1900028516 (http://www.chictr.org.cn/index.aspx). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12944-021-01475-z. BioMed Central 2021-05-06 /pmc/articles/PMC8101132/ /pubmed/33957898 http://dx.doi.org/10.1186/s12944-021-01475-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xue, Yuzhou
Shen, Jian
Hong, Weifeng
Zhou, Wei
Xiang, Zhenxian
Zhu, Yuansong
Huang, Chuiguo
Luo, Suxin
Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles
title Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles
title_full Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles
title_fullStr Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles
title_full_unstemmed Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles
title_short Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles
title_sort risk stratification of st-segment elevation myocardial infarction (stemi) patients using machine learning based on lipid profiles
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101132/
https://www.ncbi.nlm.nih.gov/pubmed/33957898
http://dx.doi.org/10.1186/s12944-021-01475-z
work_keys_str_mv AT xueyuzhou riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles
AT shenjian riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles
AT hongweifeng riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles
AT zhouwei riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles
AT xiangzhenxian riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles
AT zhuyuansong riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles
AT huangchuiguo riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles
AT luosuxin riskstratificationofstsegmentelevationmyocardialinfarctionstemipatientsusingmachinelearningbasedonlipidprofiles